Scientific Advisory Board



Professor of Medicine, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Harvard Medical School
Investigator, Howard Hughes Medical Institute
Associate Director, Basic Science, Dana-Farber Cancer Institute/Harvard Cancer Center


William G. Kaelin, Jr., M.D. is a Professor in the Department of Medicine at the Dana-Farber Cancer Institute, Harvard Medical School and Associate Director, Basic Science for the Dana-Farber/Harvard Cancer Center. He obtained his undergraduate and M.D. degrees from Duke University and completed his training in internal medicine at the Johns Hopkins Hospital where he served as Chief Medical Resident. He was a clinical fellow in medical oncology at the Dana-Farber Cancer Institute, during which time he was a McDonnell Scholar. Dr. Kaelin is a member of The American Society for Clinical Investigation and the Institute of Medicine (IOM). He recently served on the National Cancer Institute Board of Scientific Advisors, the American Association for Cancer Research (AACR) Board of Trustees, and the IOM National Cancer Policy Board. He is a recipient of the Paul Marks Prize for Cancer Research from the Memorial Sloan-Kettering Cancer Center and the Richard and Hinda Rosenthal Prize from the AACR. In April 2010, Dr. Kaelin was named one of five recipients of the prestigious Canada Gairdner International Award, and he also was elected to the National Academy of Sciences. A Howard Hughes Medical Investigator since 1998, Dr. Kaelin’s research seeks to understand how, mechanistically, mutations affecting tumor-suppressor genes cause cancer. His long-term goal is to lay the foundation for new anticancer therapies based on the biochemical functions of such proteins.